HOYA Corporation
7741
Rangering i aksjer
#414
Globally recognized as a med-tech innovator, HOYA Corporation is a prominent... Globally recognized as a med-tech innovator, HOYA Corporation is a prominent provider of advanced technology and healthcare solutions worldwide. Its comprehensive portfolio of life care products encompasses vision correction items such as eyeglasses and contact lenses, alongside sophisticated medical devices including endoscopes, intraocular lenses, and surgical instruments for laparoscopic procedures. HOYA also supplies automated endoscope cleaning systems and various medical essentials like prosthetic ceramic fillers and metallic implants. Complementing its medical offerings, the company operates Eyecity, a specialized retail chain for contact lenses. In the realm of information technology, HOYA manufactures crucial components such as mask blanks and photomasks for semiconductor and liquid crystal display fabrication, as well as glass disks for hard disk drives. Its imaging products segment includes optical glasses, specialized lenses, colored glass filters, and laser/UV light source equipment. Furthermore, the company extends its expertise into software and cloud services, offering ReadSpeaker, a speech synthesis application, and cloud platforms like Kinnosuke for time and attendance management, and Yonosuke for electronic payslip distribution. HOYA Corporation, established in 1941, is headquartered in Tokyo, Japan.
Aksjekurs
$170.48
Markedsverdi
$57.03B
Endring (1 dag)
1.60%
Endring (1 år)
12.48%
Land
JP
Handel HOYA Corporation (7741)
Kategori
Healthcare
P/E-forhold for HOYA Corporation (7741)
P/E-forhold per October 2026 TTM: 33.39
Ifølge HOYA Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 33.39. Ved slutten av 2025 hadde selskapet en P/E på 28.86.
P/E-forholdshistorikk for HOYA Corporation fra 2001 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 33.39 | 15.68% |
| 2025 | 28.86 | -21.00% |
| 2024 | 36.53 | 17.86% |
| 2023 | 30.99 | -1.37% |
| 2022 | 31.43 | -18.86% |
| 2021 | 38.73 | 27.68% |
| 2020 | 30.34 | 30.41% |
| 2019 | 23.26 | 13.34% |
| 2018 | 20.53 | -14.95% |
| 2017 | 24.13 | 27.09% |
| 2016 | 18.99 | -13.98% |
| 2015 | 22.07 | -7.07% |
| 2014 | 23.75 | 126.64% |
| 2013 | 10.48 | -43.52% |
| 2012 | 18.56 | 35.40% |
| 2011 | 13.71 | -49.19% |
| 2010 | 26.98 | -18.92% |
| 2009 | 33.27 | 168.75% |
| 2008 | 12.38 | -38.73% |
| 2007 | 20.21 | -26.89% |
| 2006 | 27.64 | 60.02% |
| 2005 | 17.27 | -3.03% |
| 2004 | 17.81 | -57.38% |
| 2003 | 41.79 | -4.93% |
| 2002 | 43.96 | 1.40% |
| 2001 | 43.35 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 51.86 | 55.33% |
US
|
|
| 32.35 | -3.10% |
FR
|
|
| 58.54 | 75.33% |
US
|
|
| 51.87 | 55.36% |
CH
|
|
| 40.06 | 20.00% |
US
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.